Skip to content
healthcare.dev

TAPENTADOL

NDC 0054-0939, Tapentadol Hydrochloride, tablet, film coated, extended release, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0939
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA200533
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0939 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAPENTADOL HYDROCHLORIDE200 mg/1

Pharmacologic classes

Opioid Agonist [EPC]; Opioid Agonists [MoA]

Package NDCNDC-11Package
0054-0939-210005409392160 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0054-0939-21)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/38de863e-56ff-4c43-9ab8-9b3e1ba82858
  • NADAC price for package 00054093921

    GET /v1/drugs/nadac/00054093921

Use it

Look up 0054-0939 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0939 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0939. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.